Skip to main content

Table 4 Time to thrombosis according to therapy

From: Acquired activated protein C resistance and thrombosis in multiple myeloma patients

Patient

Therapy

Time to thrombosis Months

APC-R Yes/Not

1

TD

6

Yes

2

TD

7

Yes

3

TD

8

Yes

4

TD

6

Yes

5

TD

6

Not

6

VAD-T

3

Not

7

VAD

2

Not

8

VAD

2

Not

  1. p value 0.007 time to thrombosis between TD and VAD therapy.
  2. TD: Thalidomide plus dexamethasone, VAD; Vincristine, Doxorubicin and Dexamethasone; VAD-T: VAD plus thalidomide; APC-R Acquired activated protein C resistance.